[Conformational-functional relationships of tetragastrin analogs]. 1991

G V Nikiforovich, and I T Liepinia, and V M Tseĭtin, and M D Shenderovich, and S G Galaktionov

Sets of low-energy backbone conformations of the active tetragastrin analogue Boc-Trp-Leu-Asp-Phe-NH2 and two competitive antagonists Boc-Trp-Leu psi (CH2NH)-Asp-Phe-NH2 and Boc-Trp-Leu-Asp-O-CH2-CH2-C6H5 were obtained using theoretical conformational analysis methods. Groups of the conformations were selected for the three analogues, allowing a spatial matching of Trp, Asp and Phe residues responsible for the gastrin receptor binding. Three conformations possessing the lowest energies among the geometrically similar structures of these three peptides are suggested as a model for the "receptor-bound" conformations of these analogues. Backbone spatial folding resembling an alpha-helix turn is characteristic of these conformations. The correspondence of the proposed model to the available data on structure--activity relationships for tetragastrin analogues is discussed. Orientations of the putative receptor-bound conformations in a "water--lypophylic medium" two-phase system were investigated.

UI MeSH Term Description Entries
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D011377 Proglumide A drug that exerts an inhibitory effect on gastric secretion and reduces gastrointestinal motility. It is used clinically in the drug therapy of gastrointestinal ulcers. Xylamide,Milid,Xilamide
D011487 Protein Conformation The characteristic 3-dimensional shape of a protein, including the secondary, supersecondary (motifs), tertiary (domains) and quaternary structure of the peptide chain. PROTEIN STRUCTURE, QUATERNARY describes the conformation assumed by multimeric proteins (aggregates of more than one polypeptide chain). Conformation, Protein,Conformations, Protein,Protein Conformations
D011949 Receptors, Cholecystokinin Cell surface proteins that bind cholecystokinin (CCK) with high affinity and trigger intracellular changes influencing the behavior of cells. Cholecystokinin receptors are activated by GASTRIN as well as by CCK-4; CCK-8; and CCK-33. Activation of these receptors evokes secretion of AMYLASE by pancreatic acinar cells, acid and PEPSIN by stomach mucosal cells, and contraction of the PYLORUS and GALLBLADDER. The role of the widespread CCK receptors in the central nervous system is not well understood. CCK Receptors,Caerulein Receptors,Cholecystokinin Octapeptide Receptors,Cholecystokinin Receptors,Pancreozymin Receptors,Receptors, CCK,Receptors, Caerulein,Receptors, Pancreozymin,Receptors, Sincalide,Sincalide Receptors,CCK Receptor,CCK-4 Receptors,CCK-8 Receptors,Cholecystokinin Receptor,Receptors, CCK-4,Receptors, CCK-8,Receptors, Cholecystokinin Octapeptide,CCK 4 Receptors,CCK 8 Receptors,Octapeptide Receptors, Cholecystokinin,Receptor, CCK,Receptor, Cholecystokinin,Receptors, CCK 4,Receptors, CCK 8
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D013758 Tetragastrin L-Tryptophyl-L-methionyl-L-aspartyl-L-phenylalaninamide. The C-terminal tetrapeptide of gastrin. It is the smallest peptide fragment of gastrin which has the same physiological and pharmacological activity as gastrin. CCK-4,Cholecystokinin-Tetrapeptide,Gastrin Tetrapeptide,AOC-Tetragastrin,AOC-Tetrapeptide,CCK (30-33),CKK-4,Cholecystokinin (30-33),Cholecystokinin 4,AOC Tetragastrin,AOC Tetrapeptide,Cholecystokinin Tetrapeptide,Tetrapeptide, Gastrin

Related Publications

G V Nikiforovich, and I T Liepinia, and V M Tseĭtin, and M D Shenderovich, and S G Galaktionov
November 1972, Proceedings of the National Academy of Sciences of the United States of America,
G V Nikiforovich, and I T Liepinia, and V M Tseĭtin, and M D Shenderovich, and S G Galaktionov
February 1998, Biochemical Society transactions,
G V Nikiforovich, and I T Liepinia, and V M Tseĭtin, and M D Shenderovich, and S G Galaktionov
August 2005, Biochemistry. Biokhimiia,
G V Nikiforovich, and I T Liepinia, and V M Tseĭtin, and M D Shenderovich, and S G Galaktionov
January 1983, Chemico-biological interactions,
G V Nikiforovich, and I T Liepinia, and V M Tseĭtin, and M D Shenderovich, and S G Galaktionov
February 1984, International journal of peptide and protein research,
G V Nikiforovich, and I T Liepinia, and V M Tseĭtin, and M D Shenderovich, and S G Galaktionov
December 1990, Bioorganicheskaia khimiia,
G V Nikiforovich, and I T Liepinia, and V M Tseĭtin, and M D Shenderovich, and S G Galaktionov
November 1975, Journal of medicinal chemistry,
G V Nikiforovich, and I T Liepinia, and V M Tseĭtin, and M D Shenderovich, and S G Galaktionov
January 1988, NIDA research monograph,
G V Nikiforovich, and I T Liepinia, and V M Tseĭtin, and M D Shenderovich, and S G Galaktionov
June 1976, Biochemistry,
G V Nikiforovich, and I T Liepinia, and V M Tseĭtin, and M D Shenderovich, and S G Galaktionov
January 1987, Journal of cardiovascular pharmacology,
Copied contents to your clipboard!